skip to Main Content

‘Time Machine’ Offers New Pancreatic Cancer Drug Testing Approach

Newsfeed image, light gray text on dark gray background
Many patients with pancreatic cancer have only about a 10% chance of survival within five years of their diagnosis because they tend to become resistant to chemotherapy, past studies have indicated.

A “time machine” that Purdue University engineers designed to observe pancreatic cancer behavior over time suggests a new drug testing approach that could help scientists better catch resistance. Read more . . . 


Back To Top